Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Reducing the Odds: Preventing Perinatal Transmission of HIV In The United States.

Institute of Medicine (US) Committee on Perinatal Transmission of HIV, National Research Council (US) and Institute of Medicine (US) Board on Children, Youth, and Families; Stoto MA, Almario DA, McCormick MC, editors.

Washington (DC): National Academies Press (US); 1999.

2.

Prenatal screening for HIV: A review of the evidence for the U.S. Preventive Services Task Force.

Chou R, Smits AK, Huffman LH, Fu R, Korthuis PT; US Preventive Services Task Force..

Ann Intern Med. 2005 Jul 5;143(1):38-54. Review.

PMID:
15998754
3.

Screening for HIV: recommendation statement.

US Preventive Services Task Force..

Ann Intern Med. 2005 Jul 5;143(1):32-7. No abstract available.

PMID:
15998753
4.
5.

Primary care guidelines for the management of persons infected with human immunodeficiency virus: recommendations of the HIV Medicine Association of the Infectious Diseases Society of America.

Aberg JA, Gallant JE, Anderson J, Oleske JM, Libman H, Currier JS, Stone VE, Kaplan JE; HIV Medicine Association of the Infectious Diseases Society of America..

Clin Infect Dis. 2004 Sep 1;39(5):609-29. Epub 2004 Aug 11. No abstract available.

PMID:
15356773
6.

Trends in interventions to reduce perinatal human immunodeficiency virus type 1 transmission in North Carolina.

Fiscus SA, Adimora AA, Funk ML, Schoenbach VJ, Tristram D, Lim W, McKinney R, Rupar D, Woods C, Wilfert C.

Pediatr Infect Dis J. 2002 Jul;21(7):664-8.

PMID:
12237600
7.

Zidovudine and perinatal human immunodeficiency virus type 1 transmission: a population-based approach.

Harris NS, Thompson SJ, Ball R, Hussey J, Sy F.

Pediatrics. 2002 Apr;109(4):e60.

PMID:
11927733
8.

Revised recommendations for HIV screening of pregnant women.

Centers for Disease Control and Prevention..

MMWR Recomm Rep. 2001 Nov 9;50(RR-19):63-85; quiz CE1-19a2-CE6-19a2.

9.

Public Health Service Task Force recommendations for use of antiretroviral drugs in pregnant HIV-1-infected women for maternal health and interventions to reduce perinatal HIV-1 transmission in the United States (revised November 3, 2000).

United States Public Health Service Task Force. Perinatal HIV Guidelines Working Group Members..

HIV Clin Trials. 2001 Jan-Feb;2(1):56-91. No abstract available.

PMID:
11590515
10.

Acceptability and impact of zidovudine for prevention of mother-to-child human immunodeficiency virus-1 transmission in France.

Mayaux MJ, Teglas JP, Mandelbrot L, Berrebi A, Gallais H, Matheron S, Ciraru-Vigneron N, Parnet-Mathieu F, Bongain A, Rouzioux C, Delfraissy JF, Blanche S.

J Pediatr. 1997 Dec;131(6):857-62.

PMID:
9427890
11.
12.

Perinatal HIV infection and the effect of zidovudine therapy on transmission in rural and urban counties.

Fiscus SA, Adimora AA, Schoenbach VJ, Lim W, McKinney R, Rupar D, Kenny J, Woods C, Wilfert C.

JAMA. 1996 May 15;275(19):1483-8.

PMID:
8622222
13.

Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group.

Connor EM, Sperling RS, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, VanDyke R, Bey M, Shearer W, Jacobson RL, et al.

N Engl J Med. 1994 Nov 3;331(18):1173-80.

Supplemental Content

Support Center